Overexpression of SerpinB9 in non-seminomatous germ cell tumors

被引:0
|
作者
Anami, Toshiki [1 ,2 ]
Ibe, Yuki [1 ,2 ]
Li, Lianbo [1 ,3 ]
Komohara, Yoshihiro [1 ,4 ]
Hirao, Hiroki [1 ,3 ]
Harada, Mamoru [5 ]
Yano, Hiromu [1 ]
Fujiwara, Yukio [1 ]
Motoshima, Takanobu [2 ]
Yatsuda, Junji [2 ]
Hibi, Taizo [3 ]
Kamba, Tomomi [2 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, 1-1-1 Honjo,Kumamoto Chuo Ku, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Urol, Kumamoto, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat Surg & Transplantat, Kumamoto, Japan
[4] Kumamoto Univ, Ctr Metab Regulat Hlth Aging, Kumamoto, Japan
[5] Shimane Univ, Dept Immunol, Fac Med, Shimane, Japan
基金
日本学术振兴会;
关键词
SerpinB9; Seminoma; Embryonal carcinoma; Yolk sac tumor; HLA; CD204-POSITIVE MACROPHAGES; TARGETS;
D O I
10.1007/s00795-023-00374-9
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serpinb9 is an inhibitor of granzyme B and is potentially involved in the immune escape of tumor cells. In the present study, bioinformatics analysis using open databases suggested that SerpinB9 is overexpressed in testicular embryonal carcinoma. Immunohistological analysis was performed on 28 cases of testicular germ cell tumors to investigate the relationship between SerpinB9 expression in testicular germ cell tumors and the tumor immune environment. SerpinB9 was significantly upregulated in the non-seminoma group and inversely correlated with the number of tumor-infiltrating CD8-positive cells. In addition, yolk sac tumors were characterized by the loss of human leukocyte antigen-class I expression. These findings suggest that SerpinB9 contributes to the immune escape of testicular germ cell tumors. Targeting therapy for SerpinB9 might therefore be useful in immunotherapy for testicular germ cell tumors resistant to immune checkpoint inhibitors.
引用
收藏
页码:45 / 58
页数:14
相关论文
共 50 条
  • [41] Loss of MGMT promoter methylation and resistance to cisplatin in non-seminomatous germ cell tumors
    Moutinho, Catia
    Garcia-del-Muro, Xavier
    Guino, Elisabet
    Vidal, August
    Puertas, Sara
    Munoz, Clara
    Piulats, Josep
    Villanueva, Alberto
    Esteller, Manel
    CANCER RESEARCH, 2016, 76
  • [42] COMPARISON OF 5 ONCODEVELOPMENTAL PROTEINS IN NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTES
    BRAUNSTEIN, GD
    THOMPSON, R
    MCINTIRE, KR
    CLINICAL RESEARCH, 1983, 31 (02): : A403 - A403
  • [43] Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
    Oosting, S. F.
    de Haas, E. C.
    Links, T. P.
    de Bruin, D.
    Sluiter, W. J.
    de Jong, I. J.
    Hoekstra, H. J.
    Sleijfer, D. T.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 104 - 108
  • [44] Primary mediastinal non-seminomatous germ-cell tumors: From clinics to biology
    Fizazi, K
    Culine, S
    Droz, JP
    LeChevalier, T
    Ruffie, P
    Theodore, C
    BULLETIN DU CANCER, 1997, 84 (03) : 313 - 327
  • [45] DECREASING UTILIZATION OF RPLND FOR CLINICAL STAGE I NON-SEMINOMATOUS GERM CELL TUMORS
    Navai, Neema
    Shikanov, Sergey
    Pisters, Louis
    Eggener, Scott
    JOURNAL OF UROLOGY, 2012, 187 (04): : E305 - E305
  • [46] TUMOR-MARKERS IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    WILLEMSE, PHB
    SLEIJFER, DT
    KOOPS, HS
    DEBRUIJN, HWA
    OOSTERHUIS, JW
    BROUWERS, TM
    OCKHUIZEN, T
    MARRINK, J
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (1-2): : 117 - 128
  • [47] INTENSIVE INDUCTION CHEMOTHERAPY FOR POOR RISK NON-SEMINOMATOUS GERM-CELL TUMORS
    HORWICH, A
    BRADA, M
    NICHOLLS, J
    JAY, G
    HENDRY, WF
    DEARNALEY, D
    PECKHAM, MJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 177 - 184
  • [48] Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors
    Scavuzzo, A.
    Crescio, E.
    Figueroa Rodriguez, P. A.
    Duran Chable, D. L.
    Rios Garcia, C. A.
    Jimenez Guedulain, N.
    Calvo Vazquez, I
    Jimenez Rios, M. A.
    EUROPEAN UROLOGY, 2023, 83
  • [49] Results of multimodality therapy in poor risk non-seminomatous germ cell tumors (NSGCT)
    Omuro, Y
    Sasaki, E
    Hayashi, C
    Okamoto, R
    Kobayashi, T
    Maeda, Y
    Sasaki, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 430 - 430
  • [50] COMPUTED-TOMOGRAPHY IN PRIMARY NON-SEMINOMATOUS GERM-CELL TUMORS OF THE MEDIASTINUM
    BLOMLIE, V
    LIEN, HH
    FOSSA, SD
    JACOBSEN, AB
    STENWIG, AE
    ACTA RADIOLOGICA, 1988, 29 (03) : 289 - 292